The effect of alpha blockade on iontophoresis-induced ocular shedding of latent HSV-1 W in different host animals.
Previous studies demonstrated that non-specific beta blockade promoted ocular shedding of latent HSV-1 in the mouse and rabbit iontophoresis models. The present study examined the effect of topical alpha blockers, thymoxamine and corynanthine, on reactivation and induced ocular shedding of latent HSV-1 W in different host animals. Latent trigeminal ganglionic infection was established in Balb/c mice and New Zealand rabbits following corneal inoculation with HSV-1 W strain, and later confirmed by co-cultivation. Treatment with coded eye drops (thymoxamine, corynanthine or BSS was begun one day prior to iontophoresis induction and continued BID OU for 5 days. Reactivation and recovery of latent HSV-1 was determined by daily ocular swabs, and characteristic HSV-1 cytopathic effect in Vero cells. In Balb/c mice, topical administration of thymoxamine 0.5% or corynanthine 5% significantly reduced the number of virus-positive eyes, virus-positive mice, and total virus-positive swabs per experiment, whereas the inhibitory effect was minimal in NZ rabbits. We conclude that alpha blockade may alter the reactivation signal that is mediated via the adrenergic system, and that different host factors (as expressed in different species) may play an important role in this process.
Gordon
Y J
YJ
Eye and Ear Institute of Pittsburgh, PA.
Romanowski
E
E
Harwick
J
J
Berman
J
J
Olsakovsky
L
L
Araullo-Cruz
T
T
D000287:Administration, Topical; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002478:Cells, Cultured; D016009:Chi-Square Distribution; D003315:Cornea / Q000187:drug effects / Q000382:microbiology*; D005260:Female; D007478:Iontophoresis; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D013948:Moxisylyte / Q000008:administration & dosage / Q000494:pharmacology; D011817:Rabbits; D011897:Random Allocation; D018139:Simplexvirus / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D012668:Trigeminal Ganglion / Q000382:microbiology; D014775:Virus Activation / Q000187:drug effects; D015016:Yohimbine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D015016:Yohimbine; D013948:Moxisylyte